Page 54 - IJB-10-6
P. 54
International Journal of Bioprinting Semi-solid extrusion for pediatric medicine
Continued
Ref. 92 93 94 95 96 97 98 99 100 101
Formulation of a floating drug delivery system in a single step with coaxial SSE 3D printing using ionotropic Manufacturing parameters and quality control of 3D printed dosage forms based on EP; the study demonstrated the suitability of testing for dissolution, uniformity of mass, and content uniformity according to The dosage form demonstrated sufficient buoyancy after Dosage form made using MESO-PP Co-extrusion of crosslinking ink and sodiu
Commentaries gelation of sodium alginate EP tests. 10 h ink feeds and children adherence resource settings
Sodium alginate, hydroxyethyl cellulose, calcium chloride, Tween 85 Polysorbate 80; Gelucire ® 48/16 HPMC; alpha-lactose monohydrate; microcrystalline cellulose; PVP Crosslinking ink: water; ethanol; calcium chloride; hydroxyethyl cellulose; Tween ® 85 Alginate ink: sodium alginate solution Pectin, sorbitol, citric acid anhydrous, Sucrose, pectin, maltodextrin, water, maltitol, flavorings (lemon, vanilla, peach), Formulation 1: Water, soy
Excipients Gelucire 50/13 maltitol colorants, citric acid water
Propranolol hydrochloride Furosemide and sildenafil citrate Famotidine Niclosamide Ricobendazole Simethicone Isoleucine or valine or citrulline Fenofibrate Omeprazole (7 mg) Isoniazid
API (12.5%)
Formulation details and properties Gastric floating delivery system Controlled-release intragastric floating printlets Controlled-release gastro- floating printlets Gastroretentive printlets Gastro-floating printlets Pectin-based drug-loaded gummies 3D-printed chewable medicines containing amino acids Emulsion gel for solid dosage forms (immediate release) Formulation of gastro- resistant chewable printlets from enteric omep
Table 1. Continued Formulation type Swallowable printlets Chewable printlets
Volume 10 Issue 6 (2024) 46 doi: 10.36922/ijb.4063

